SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-031286
Filing Date
2021-06-02
Accepted
2021-06-02 09:16:17
Documents
12
Period of Report
2021-06-02
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K crsp-8k_20210602.htm   iXBRL 8-K 36110
  Complete submission text file 0001564590-21-031286.txt   160651

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA crsp-20210602.xsd EX-101.SCH 5776
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE crsp-20210602_lab.xml EX-101.LAB 18642
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crsp-20210602_pre.xml EX-101.PRE 11151
5 EXTRACTED XBRL INSTANCE DOCUMENT crsp-8k_20210602_htm.xml XML 3398
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 21987838
SIC: 2836 Biological Products, (No Diagnostic Substances)